REGULATION OF HSV GENE EXPRESSION BY HCF
HCF 对 HSV 基因表达的调控
基本信息
- 批准号:6636431
- 负责人:
- 金额:$ 27.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-03-01 至 2006-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (taken from Investigator's abstract):Productive infection by herpes
simplex virus (HSV) is stimulated by the virally-encoded transcription factor
VP16, which associates with the cellular transcription factor HCF-1 to form a
multiprotein-DNA complex on each of the five viral immediate-early (IE) gene
promoters. Failure of HSV to express sufficient levels of IE gene products may
lead to the establishment of a latent infection in appropriate cell types such
as sensory neurons. The importance of HCF-1 to the viral productive cycle is
most clearly demonstrated by infection of cells with a conditionally
inactivated version of HCF-1. This results in a significant delay in viral gene
expression and severely reduced virus yield. Dr. Wilson proposes that
differences in the activity or localization of HCF-1 in sensory neurons
contribute to the establishment or maintenance of viral latency. In these
cells, HCF-1 is found predominantly in cytoplasm, a striking contrast to most
other cell types where HCF-1 is predominantly nuclear. Signals that promote
reactivation also trigger a rapid relocalization of HCF-1 to the nucleus. To
this end, they have identified a novel HCF-1 associated protein with
characteristics of a nucleocytoplasmic shuttle factor that may be responsible
for the dynamic localization of HCF-1 in neurons. Regulation of HCF-1
localization may also be important in other contexts. HCF-1 is required for
transcriptional activation by a number of DNA-binding proteins and loss of
HCF-1 leads to an arrest in G1 phase of the cell cycle. The aims of this
proposal are to: (Aim 1) understand how VP16 and the novel shuttle protein
(designated HPIP) selectively target HCF-1 rather than the close-relative
HCF-2; (Aim 2) demonstrate suppression of IE gene expression by the candidate
shuttle proteins (HPIP) and establish its mode of action in sensory neurons and
other cell types; and (Aim 3) test the hypothesis that HCF-1 stimulates IE gene
activation by interacting with additional transcription factors bound to sites
flanking the VP16-responsive elements in each IE promoter. The investigator
suggests that the pivotal role of HCF-1 in initiating viral IE gene expression
represents an important target for the design of new therapeutic strategies to
combat human diseases that arise from HSV infection.
描述(摘自研究者摘要):疱疹引起的生产性感染
单纯病毒(HSV)由病毒编码的转录因子刺激
VP 16,它与细胞转录因子HCF-1结合形成
5种病毒即早(IE)基因中每一种上的多蛋白-DNA复合物
发起人。HSV不能表达足够水平的IE基因产物可能
导致在适当的细胞类型中建立潜伏感染,
作为感觉神经元。HCF-1对病毒生产周期的重要性是
最清楚地证明了感染细胞的条件
HCF-1的灭活版本。这导致了病毒基因的显著延迟,
表达并严重降低病毒产量。威尔逊博士建议,
感觉神经元中HCF-1活性或定位的差异
有助于病毒潜伏期的建立或维持。在这些
HCF-1主要存在于细胞质中,与大多数细胞形成鲜明对比。
HCF-1主要是核的其他细胞类型。促进的信号
重新激活还引发HCF-1快速重新定位到细胞核。到
为此,他们鉴定了一种新的HCF-1相关蛋白,
核质穿梭因子的特性,
用于HCF-1在神经元中的动态定位。HCF-1的调节
本地化在其它环境中也可能是重要的。需要HCF-1
转录激活的DNA结合蛋白和损失的数量
HCF-1导致细胞周期停滞在G1期。其目的是
目的1:了解VP 16和新型穿梭蛋白如何在细胞内表达,
(指定为HPIP)选择性靶向HCF-1,而不是近亲
HCF-2;(目的2)证明候选物抑制IE基因表达
穿梭蛋白(HPIP),并建立其在感觉神经元中的作用模式,
目的3:验证HCF-1刺激IE基因的假说
通过与结合位点的额外转录因子相互作用激活
位于每个IE启动子中的VP 16应答元件的侧翼。研究者
提示HCF-1在启动病毒IE基因表达中的关键作用
代表了设计新治疗策略的重要目标,
对抗由HSV感染引起的人类疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANGUS WILSON其他文献
ANGUS WILSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANGUS WILSON', 18)}}的其他基金
Viral disruption of host transcriptome integrity
病毒破坏宿主转录组完整性
- 批准号:
10666992 - 财政年份:2023
- 资助金额:
$ 27.09万 - 项目类别:
Viral disruption of host transcriptome integrity
病毒破坏宿主转录组完整性
- 批准号:
10641602 - 财政年份:2022
- 资助金额:
$ 27.09万 - 项目类别:
相似海外基金
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10448505 - 财政年份:2021
- 资助金额:
$ 27.09万 - 项目类别:
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10312411 - 财政年份:2021
- 资助金额:
$ 27.09万 - 项目类别:
Increasing efficiency in formation of chimeric proteins
提高嵌合蛋白形成的效率
- 批准号:
561998-2021 - 财政年份:2021
- 资助金额:
$ 27.09万 - 项目类别:
University Undergraduate Student Research Awards
Decoration and Dimerization of Chimeric Proteins Mediated by Coiled-Coil Interactions
卷曲螺旋相互作用介导的嵌合蛋白的修饰和二聚化
- 批准号:
537306-2018 - 财政年份:2019
- 资助金额:
$ 27.09万 - 项目类别:
Collaborative Research and Development Grants
Exploring the therapeutic potential of chimeric proteins
探索嵌合蛋白的治疗潜力
- 批准号:
1947736 - 财政年份:2017
- 资助金额:
$ 27.09万 - 项目类别:
Studentship
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
- 批准号:
8364271 - 财政年份:2011
- 资助金额:
$ 27.09万 - 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
- 批准号:
8444422 - 财政年份:2010
- 资助金额:
$ 27.09万 - 项目类别:
Cat allergen-human Fc-gamma1 chimeric proteins to treat cat allergy
猫过敏原-人Fc-gamma1嵌合蛋白治疗猫过敏
- 批准号:
7907314 - 财政年份:2010
- 资助金额:
$ 27.09万 - 项目类别:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
- 批准号:
8171849 - 财政年份:2010
- 资助金额:
$ 27.09万 - 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
- 批准号:
8313432 - 财政年份:2010
- 资助金额:
$ 27.09万 - 项目类别: